After the pandemic derailed the market in Q220, Total Joints was getting back on track in Q3
The COVID-19 pandemic derailed the Total Joints Market in Q220 with stay-at-home orders and elective procedure shutdowns. But the market seemed back on track in Q320 as elective procedural volumes increased and revenues neared pre-COVID levels. With the market chugging along, the US Total Joints Market experienced positive growth during the quarter of +2.5%, according to SmartTRAK Financial Dashboard. The Hip Market was able to quickly gain steam due to the less elective nature of the procedure compared to Knees. In Q320, the US Hip Market grew +7.6% compared to the US Knee Market which was nearing pre-COVID levels at -1.1%.
Among the many topics covered in the comprehensive Q320 Total Joints Market Recap* are:
- Complete Total Joints Market Overview
- Companies' Revenue and Market Shares
- Knee Overview including Q320 Highlights
- Hip Overview including Q320 Highlights
- Q320 Regulatory Highlights
For Q320, Zimmer Biomet remained at the top of the US Knee Replacement Market with % share followed by Stryker, JNJ/DePuy Synthes and Smith & Nephew and Other companies. Zimmer Biomet retained the top spot in the US Hip Replacement Market with % share with Stryker in second place, slightly above JNJ/DePuy Synthes and then followed by Smith & Nephew and ...
Read the entire Q320 Total Joints Market Recap including news, data, charts, company revenues, shares and analysis*
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.